{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:59Z","timestamp":1786119479157,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/meg.0b013e328332a360","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T04:08:27Z","timestamp":1268194107000},"page":"457-460","source":"Crossref","is-referenced-by-count":18,"title":["Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series"],"prefix":"10.1097","volume":"22","author":[{"given":"Judith M.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hodgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan H.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210207","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticoids for alcoholic hepatitis \u2013 a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomised clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Alim Pharm Ther"},{"key":"R2-11-20210207","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American college of gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R3-11-20210207","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"R4-11-20210207","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"R5-11-20210207","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00042737-200507000-00011","article-title":"Bilirubin response to corticosteroids in severe alcoholic hepatitis","volume":"17","author":"Morris","year":"2005","journal-title":"Eur J Gastro Hep"},{"key":"R6-11-20210207","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"R7-11-20210207","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.1990.tb00482.x","article-title":"Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis","volume":"14","author":"Felver","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"R8-11-20210207","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"R9-11-20210207","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2004.04.028","article-title":"Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis","volume":"41","author":"Spahr","year":"2004","journal-title":"J Hepatol"},{"key":"R10-11-20210207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"R11-11-20210207","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"R12-11-20210207","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomised controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"R13-11-20210207","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomised double-blinded, placebo controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"R14-11-20210207","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leuocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Trans Apher Sci"},{"key":"R15-11-20210207","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","article-title":"Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis","volume":"47","author":"Kashiwagi","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R16-11-20210207","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jca.20053","article-title":"In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects","volume":"20","author":"Ramlow","year":"2005","journal-title":"J Clin Apher"},{"key":"R17-11-20210207","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","article-title":"Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study","volume":"49","author":"Suzuki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R18-11-20210207","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R19-11-20210207","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3748\/wjg.v12.i21.3393","article-title":"Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with ulcerative colitis","volume":"12","author":"Hanai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R20-11-20210207","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-004-1253-5","article-title":"Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and \u03b22 integrin","volume":"53","author":"Takeda","year":"2004","journal-title":"Inflamm Res"},{"key":"R21-11-20210207","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(01)00276-8","article-title":"Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis","volume":"36","author":"Taieb","year":"2002","journal-title":"J Hepatol"},{"key":"R22-11-20210207","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1530-0277.1996.tb01708.x","article-title":"Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in \u03b1-fetoprotein","volume":"20","author":"Mendenhall","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"R24-11-20210207","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hepres.2006.06.016","article-title":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis: a preliminary report","volume":"36","author":"Kumashiro","year":"2006","journal-title":"Hepatol Res"},{"key":"R25-11-20210207","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/01.ALC.0000078607.32247.9D","article-title":"Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report","volume":"27","author":"Tsuji","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"R26-11-20210207","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors related to mortality in alcoholic hepatitis and the derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MEG.0b013e328332a360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:21:00Z","timestamp":1786040460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042737-201004000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0b013e328332a360","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}